Dr. Gosselin handles the drug product formulation and process development of new chemical entities. He also oversees Phase I, II and early Phase III clinical trial material manufacturing. He has a bachelor’s degree in chemical engineering and a doctorate in pharmaceutical technology, both awarded by the Université de Montréal.
Dr. Gosselin has a background in pharma development. He worked for several major companies in a variety of roles, such as R&D project leader for the German company ratiopharm international. While at ratiopharm, he contributed to the development of a range of products and helped establish a center of excellence in R&D.
Dr. Gosselin is an associate professor at the Université du Québec à Montréal. He has published an array of material, including peer-reviewed publications and patents.